Trump Vaccine Czar Still Stands to Profit

(Trump Chief Adviser Monecef Slaoui with Trump, speaking on vaccine development on May 15, 2020, in the Rose Garden of the White House. Photo by Mandel Ngan/AFP via Getty Images.) The Trump administration has announced an ambitious plan to develop and produce millions of doses of a new COVID-19 vaccine by the end of 2020, a lofty and risky process that stands to shift conventional wisdom about the vaccine process and seems to have yielded substantial stock profits for the pharmaceutical executive Trump has appointed to lead the initiative.

Read →